@article{03c58d7e88324da6b8e67ca2bab0c43c,
title = "Stability of Programmable Shunt Valve Settings with Simultaneous Use of the Optune Transducer Array: A Case Report.",
author = "Chan, \{Andrew K\} and Birk, \{Harjus S\} and Winkler, \{Ethan A\} and Viner, \{Jennifer A\} and Taylor, \{Jennie W\} and McDermott, \{Michael W\}",
note = "The Optune{\textregistered} transducer array (Novocure Ltd., Haifa, Israel) is an FDA-approved noninvasive regional therapy that aims to inhibit the growth of glioblastoma multiforme (GBM) cells via utilization of alternating electric fields. Some patients with GBM may develop hydrocephalus and benefit from subsequent shunt placement, but special attention must be paid to patients in whom programmable valves are utilized, given the potential effect of the magnetic fields on valve settings.",
year = "2016",
month = jul,
day = "7",
doi = "10.7759/CUREUS.675",
language = "American English",
volume = "8",
journal = "Cureus",
}